Fc receptor beta chain deficiency exacerbates murine arthritis in the anti-type II collagen antibody-induced experimental model

REFERENCES

• Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996;85:307–10.
   Google Scholar
• Corr M, Crain B. The role of FcyR signaling in the K/BxN serum transfer model of arthritis. J Immunol. 2002;169:6604–9.
   PubMed Web of Science ®Google Scholar
• Mancardi DA, Jonsson F, Iannascoli B, Khun H, Van Rooijen N, Huerre M, et al. Cutting edge: the murine high-affinity IgG receptor FeyRIV is sufficient for autoantibody-induced arthritis. J Immunol. 2011;186:1899–903.
   PubMed Web of Science ®Google Scholar
• Kagari T, Tanaka D, Doi H, Shimozato T. Essential role of Fey receptors in anti-type II collagen antibody-induced arthritis. J Immunol. 2003;170:4318–24.
   PubMed Web of Science ®Google Scholar
• Hiraoka S, Furumoto Y, Koseki H, Takagaki Y, Taniguchi M, Okumura K, et al. Fe receptor /3 subunit is required for full activation of mast cells through Fe receptor engagement. Int Immunol. 1999;11:199–207.
   PubMed Web of Science ®Google Scholar
• Bromley M, Fisher WD, Woolley DE. Mast cells at sited of cartilage erosion in the rheumatoid joint. Ann Rheum Dis. 1984;43:76–9.
   PubMedGoogle Scholar
• Nigrovic PA, Lee DM. Synovial mast cells: role in acute and chronic arthritis. Immunol Rev. 2007;217:19–37.
   PubMed Web of Science ®Google Scholar
• Sawamukai N, Saito K, Yamaoka K, Nakayamada S, Ra C, Tanaka Y. Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells. J Immunol. 2007;179:6479–84.
   PubMed Web of Science ®Google Scholar
• Juurikivi A, Sandler C, Lindstedt KA, Kovanen PT, Juutilainen T, Leskinen MJ, et al. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis. Ann Rheum Dis. 2005;64:1126–31.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Nunomura S, Gon Y, Endo D, Kishiro S, Fukunaga M, et al. Abrogation of high-affinity IgE receptor-mediated mast cell activation at the effector phase prevents contact hypersensi-tivity to oxazolone. J Invest Dermatol. 2010;130:725–31.
   PubMed Web of Science ®Google Scholar
• Zhou JS, Xing W, Friend DS, Austen KF, Katz HR. Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis. J Exp Med. 2007;204:2797–802.
   Google Scholar
• Rittirsch D, Flied MA, Day DE, Nadeau BA, Zetoune FS, Sarma JV, et al. Cross-talk between TLR4 and FeyReceptorIII (CD16) pathways. PLoS Pathog. 2009;5(6):e1000464.
   Web of Science ®Google Scholar
• Nimmeijahn F, Ravetch JV. Fe-receptors as regulators of immunity. Adv Immunol. 2007;96:179–204.
   PubMed Web of Science ®Google Scholar
• Tanaka D, Kagari T, Doi H, Shimozato T. Essential role of neutrophils in anti-type II collagen antibody and lipopoly-saccharide-induced arthritis. Immunology. 2006;119:195–202.
   PubMed Web of Science ®Google Scholar
• Joyce-Shaikh B, Bigler ME, Chao CC, Murphy EE, Blumenschein WM, Adamopoulos IE, et al. Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis. J Exp Med. 2010;207: 579–89.
   Google Scholar
• Kagari T, Doi H, Shimozato T. The importance of IL-1/3 and TNF-a, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol. 2002;169: 1459–66.
   Google Scholar
• Pettit AR, Ji H, von Stechow D, Muller R, Goldring SR, Choi YW, et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol. 2001;159:1689–99.
   PubMed Web of Science ®Google Scholar
• Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, et al. Osteoclasts are essential for TNF-a-mediated joint destruction. J Clin Invest. 2002;110:1419–27.
   Google Scholar
• Theill LE, Boyle WJ, Penninger JM. RANK-L AND RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 2002;20:795–823.
   Google Scholar
• Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, et al. Soluble interleukin-6 receptor triggers osteo-clast formation by interleukin-6. Proc Natl Acad Sci USA. 1993;90:11924–8.
   PubMed Web of Science ®Google Scholar
• Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD. IL-6 stimulates osteoclast-like multinucleated cell-formation in long-term human marrow cultures by inducing IL-1 release. J Immu-nol. 1990;144: 4226–30.
   Google Scholar
• Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337–42.
   Google Scholar
• Dombrowicz D, Quatannens B, Papin JP, Capron A, Capron M. Expression of a functional FceRI on rat eosinophils and macro-phages. J Immunol. 2000;165:1266–71.
   Google Scholar
• Porcherie A, Mathieu C, Peronet R, Schneider E, Claver J, Commere PH, et al. Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria. J Exp Med. 2011;208:2225–36.
   PubMed Web of Science ®Google Scholar
• Furumoto Y, Nunomura S, Terada T, Rivera J, Ra C. The FeeRI/3 immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IkappaB kinase phosphorylation and mast cell cytokine production. J Biol Chem. 2004;279: 49177–87.
   Google Scholar
• Guma M, Kashiwakura J, Crain B, Kawakami Y, Beutler B, Firestein GS, et al. JNK1 controls mast cell degranulation and IL-1/3 production in inflammatory arthritis. Proc Natl Acad Sci USA. 2010;107:22122–7.
   PubMed Web of Science ®Google Scholar
• Nigrovic PA, Binstadt BA, Monach PA, Johnsen A, Gurish M, Iwakura Y, et al. Mast cells contribute to initiation of autoanti-body-mediated arthritis via IL-1. Proc Natl Acad Sci USA. 2007;104:2325–30.
   PubMed Web of Science ®Google Scholar
• Quinones MP, Ahuja SK, Jimenez F, Schaefer J, Garavito E, Rao A, et al. Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. J Clin Invest. 2004;113(6):856–66.
   PubMed Web of Science ®Google Scholar